Regen Biopharma Stock Today
RGBP Stock | USD 0.07 0.01 7.04% |
PerformanceOK
| Odds Of DistressHigh
|
Regen BioPharma is selling at 0.066 as of the 27th of February 2025; that is 7.04 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.066. Regen BioPharma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California. Regen Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 5.05 B outstanding shares. More on Regen BioPharma
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Regen Pink Sheet Highlights
Chairman | David Koos |
Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Regen BioPharma [RGBP] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regen BioPharma's market, we take the total number of its shares issued and multiply it by Regen BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Regen BioPharma conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 5.05 B outstanding shares.
Regen BioPharma currently holds about 110.99 K in cash with (606.92 K) of positive cash flow from operations.
Check Regen BioPharma Probability Of Bankruptcy
Ownership AllocationRegen BioPharma owns a total of 5.05 Billion outstanding shares. Roughly 99.94 pct. of Regen BioPharma outstanding shares are held by general public with 0.06 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Regen Ownership Details
Regen BioPharma Risk Profiles
Mean Deviation | 15.48 | |||
Semi Deviation | 14.49 | |||
Standard Deviation | 23.92 | |||
Variance | 572.29 |
Regen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Regen BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Additional Tools for Regen Pink Sheet Analysis
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.